✦ LIBER ✦

SB-239063, a Potent and Selective Inhibitor of P38 Map Kinase: Preclinical Pharmacokinetics and Species-Specific Reversible Isomerization

✍ Scribed by Keith W. Ward; Joel W. Proksch; Leonard M. Azzarano; Kevin L. Salyers; Jeanelle E. McSurdy-Freed; Tina M. Molnar; Mark A. Levy; Brian R. Smith

Book ID: 110318194
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 303 KB
Volume: 18
Category: Article
ISSN: 0724-8741
DOI: 10.1023/a:1013002414678

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Discovery of PH-797

ChemInform Abstract: Discovery of PH-797804, a Highly Selective and Potent Inhibitor of p38 MAP Kinase.

✍ Shaun R. Selness; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

## Abstract The synthesis and SAR studies of a novel N‐aryl pyridinone class of p38 kinase inhibitors are described.

Pharmacological profile of AW-814141, a

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

✍ Puneet Chopra; Onkar Kulkarni; Shashank Gupta; Malini Bajpai; Vijay Kanoje; Mani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 468 KB

5-Cyanopyrimidine Derivatives as a Novel

5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase

✍ Liu, Chunjian; Wrobleski, Stephen T.; Lin, James; Ahmed, Gulzar; Metzger, Axel; 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 297 KB

ChemInform Abstract: Substituted N-Aryl-

ChemInform Abstract: Substituted N-Aryl-6-pyrimidinones: A New Class of Potent, Selective, and Orally Active p38 MAP Kinase Inhibitors.

✍ Balekudru Devadas; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 22 KB 👁 1 views

## Abstract A series of highly potent and selective p38 MAP kinase inhibitors is developed originating from a substituted N‐aryl‐6‐pyrimidinone scaffold.

p38 MAP Kinase Inhibitors. Part 1. Desig

p38 MAP Kinase Inhibitors. Part 1. Design and Development of a New Class of Potent and Highly Selective Inhibitors Based on 3,4-Dihydropyrido[3,2-d]pyrimidone Scaffold.

✍ Swaminathan R. Natarajan; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 185 KB 👁 2 views

p38 MAP kinase inhibitors. part 1:

p38 MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold

✍ Swaminathan R. Natarajan; David D. Wisnoski; Suresh B. Singh; John E. Stelmach; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 153 KB